I agree with your assessment, which shows a pattern of not making good decisions by Joe / Generex. Previous deals have caused major problems and the China deal isn’t showing anything either.

Generex highlighted this deal as being so big and now they are saying they need funds in the US to do anything about a vaccine.

This just doesn’t make any sense. Is this the old Generex or the new one?

I’m starting to wonder...